According to large-scale clinical studies, low concentrations of plasma adiponectin may be a risk factor for the pathogenesis of PC, which might be related to the activation of caspases by adiponectin to promote apoptosis and the attenuation of the β-catenin signaling pathway to restrain tumor cell proliferation (30, 31). Here, ADIPOQ is linked to neoplasm.